Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomized trial showed.

We read with interest the FUTURE study by Mohamed Abdel-Fattah and colleagues, which reported on the role and cost-effectiveness of urodynamic testing in women with refractory overactive bladder ...

IRVINE, Calif.--(BUSINESS WIRE)--Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, announced today ...